Skip to main content
Clinical Trials/IRCT201601106710N6
IRCT201601106710N6
Completed
Phase 2

Clinical trial to investigate the efficacy of insulin resistance treatment with the metformin in improving mood disorders in patients with polycystic ovarian syndrome

Vice Chancellor for Research of Tabriz University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Polycystic ovary syndrome.
Sponsor
Vice Chancellor for Research of Tabriz University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice Chancellor for Research of Tabriz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients with PCOS who meet the Rotterdam criteria; with top 10 score in Anxiety Inventory and top 14 score in the Beck Depression Inventory.
  • Exclusion criteria: patient's consent to continue the study; patients who have been treated PCOS over recent 3 months; patients treated with anxiety disorders and depression; patients with diabetes; Patients with Cushing disease; hyperprolactinemia; congenital adrenal hyperplasia; Patients with serious illnesses and life threatening disease (including cancer, cirrhosis, renal failure; severe heart failure class 3 and 4 serious lung disease); pregnancy and lactation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials